{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:22:12Z","timestamp":1777029732629,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10096-021-04329-9","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T09:04:56Z","timestamp":1637139896000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic failures of targeted antibiotic prophylaxis in urology"],"prefix":"10.1007","volume":"41","author":[{"given":"Elodie","family":"Curlier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvanne","family":"Sadreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Markowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Brureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunniva","family":"Donat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Marie","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"4329_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","volume":"179","author":"JS Wolf","year":"2008","unstructured":"Wolf JS, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379\u20131390","journal-title":"J Urol"},{"issue":"8","key":"4329_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6248","volume":"1","author":"C Khaw","year":"2018","unstructured":"Khaw C, Oberle AD, Lund BC et al (2018) Assessment of guideline discordance with antimicrobial prophylaxis best practices for common urologic procedures. JAMA Netw Open 1(8):e186248. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6248","journal-title":"JAMA Netw Open"},{"key":"4329_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4111\/icu.2017.58.1.61","volume":"58","author":"J Medina-Polo","year":"2017","unstructured":"Medina-Polo J, Sope\u00f1a-Sutil R, Ben\u00edtez-Sala R et al (2017) Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a urology ward. Investig Clin Urol 58:61\u201369","journal-title":"Investig Clin Urol"},{"key":"4329_CR4","unstructured":"Enqu\u00eate nationale de pr\u00e9valence des infections nosocomiales et des traitements anti-infectieux en \u00e9tablissements de sant\u00e9, mai-juin 2017. https:\/\/www.enquete-nationale-de-prevalence-des-infections-nosocomiales-et-des-traitements-anti-infectieux-en-etablissements-de-sante-mai-juin-2017"},{"key":"4329_CR5","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s10096-020-03953-1","volume":"39","author":"B Souhail","year":"2020","unstructured":"Souhail B, Charlot P, D\u00e9roudilhes G, Coblentz Y, Pierquet G, Gimel P et al (2020) Urinary tract infection and antibiotic use around ureteral stent insertion for urolithiasis. Eur J Clin Microbial Infect Dis 39:2077\u20132083","journal-title":"Eur J Clin Microbial Infect Dis"},{"key":"4329_CR6","doi-asserted-by":"publisher","unstructured":"K\u00f6ves B, Cai T, Veeratterapillay R, Pickard R, Seisen T, Lam TB et al. Benefits and harms of treatment of asymptomatic bacteriuria: a systematic review and meta-analysis by the European Association of Urology. Eur Ass Urol. https:\/\/doi.org\/10.1016\/j.eururo.2017.07.014","DOI":"10.1016\/j.eururo.2017.07.014"},{"key":"4329_CR7","doi-asserted-by":"publisher","first-page":"ofz243","DOI":"10.1093\/ofid\/ofz243","volume":"6","author":"N Sab\u00e9","year":"2019","unstructured":"Sab\u00e9 N, Oriol I, Melilli E, Manonelles A, Bestard O, Polo C et al (2019) Antibiotic treatment versus no treatment for asymptomatic bacteriuria in kidney transplant recipients: a multicenter randomized trial. Open Forum Infect Dis 6:ofz243. https:\/\/doi.org\/10.1093\/ofid\/ofz243","journal-title":"Open Forum Infect Dis"},{"key":"4329_CR8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/cid\/ciz021","volume":"68","author":"LE Nicolle","year":"2019","unstructured":"Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D et al (2019) Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis 68:1611\u20131615","journal-title":"Clin Infect Dis"},{"key":"4329_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2016.09.0068","author":"H Kandil","year":"2016","unstructured":"Kandil H, Cramp E, Vaghela T (2016) Trends in antibiotic resistance in urologic practice. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2016.09.0068","journal-title":"Eur Urol Focus"},{"key":"4329_CR10","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","volume":"187","author":"AK Taylor","year":"2012","unstructured":"Taylor AK, Zembower TR, Nadler RB et al (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187:1275\u20131279","journal-title":"J Urol"},{"key":"4329_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170319","volume":"12","author":"L Boeri","year":"2017","unstructured":"Boeri L, Fontana M, Gallioli A, Zanetti SP, Catellani M, Longo F et al (2017) Rectal culture-guided targeted antimicrobial prophylaxis reduces the incidence of post-operative infectious complications in men at high risk for infections submitted to transrectal ultrasound prostate biopsy \u2013 results of a cross-sectional study. PLoS ONE 12:e0170319. https:\/\/doi.org\/10.1371\/journal.pone.0170319","journal-title":"PLoS ONE"},{"key":"4329_CR12","first-page":"93","volume":"21","author":"RS Concepcion","year":"2019","unstructured":"Concepcion RS, Schaeffer EM, Shore ND, Kapoor DA, Scott JA, Kirsh GM (2019) The effect of local antibiogram\u2013based augmented antibiotic prophylaxis on infection-related complications following prostate biopsy. Rev Urol 21:93\u2013101","journal-title":"Rev Urol"},{"key":"4329_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jgs.12099","volume":"61","author":"EP Peron","year":"2013","unstructured":"Peron EP, Hirsch AA, Jury LA, Jump RL, Donskey CJ (2013) Another setting for stewardship: high rate of unnecessary antimicrobial use in a Veterans Affairs long term care facility. J Am Geriat Soc 61:289\u2013290","journal-title":"J Am Geriat Soc"},{"key":"4329_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1442-2042.2004.00941.x","volume":"11","author":"R Hamasuna","year":"2004","unstructured":"Hamasuna R, Betsunoh H, Sueyoshi T, Yakushiji K, Tsukino H, Nagano M et al (2004) Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations. Inter J Urol 11:941\u2013947","journal-title":"Inter J Urol"},{"key":"4329_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/ajhp\/zxz154","volume":"76","author":"M Chen","year":"2019","unstructured":"Chen M, Buurma V, Shah M, Fahim G (2019) Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics. Am J Health Syst Pharm 76:1383\u20131394. https:\/\/doi.org\/10.1093\/ajhp\/zxz154","journal-title":"Am J Health Syst Pharm"},{"key":"4329_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1086\/514620","volume":"27","author":"MK Lacy","year":"1998","unstructured":"Lacy MK, Nicolau DP, Nightingale CH, Quintiliani R (1998) The pharmacodynamics of aminoglycosides. Clin Infect Dis 27:23\u201327","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04329-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:08:18Z","timestamp":1642597698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04329-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4329"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04329-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"12 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The antibiotic audit was sponsored by the French National Health Agency.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The patients or their relatives provided written consent for computerization of their personal data for hospitalization purposes and clinical research. Patient privacy was protected as no personal data were extracted or copied from the computerized chart.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}